Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm,Prostatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04216134
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate Carcinoma
City of Hope Medical Center 19
Very early researchActive Not RecruitingNCT05683964
What this trial is testing

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Who this might be right for
Prostate AdenocarcinomaProstate CancerMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Beth Israel Deaconess Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00108732
What this trial is testing

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Not applicableLooking for participantsNCT07686016
What this trial is testing

Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerOligometastatic Prostate Cancer+1 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 700
Early research (Phase 1)Looking for participantsNCT06801236
What this trial is testing

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Acerand Therapeutics (Hong Kong) Limited 88
Early research (Phase 1)Active Not RecruitingNCT04943536
What this trial is testing

Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Alessa Therapeutics Inc. 20
Not applicableWithdrawnNCT05454371
What this trial is testing

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer

Who this might be right for
Prostate CancerUrineLiquid Biopsy
Novosanis NV
Not applicableEnded earlyNCT03630393
What this trial is testing

Ultralow Versus Standard Pneumoperitoneum Pressure

Who this might be right for
Prostate Cancer
OhioHealth 170
Not applicableStudy completedNCT03609528
What this trial is testing

CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate Biopsies

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 40
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Not applicableStudy completedNCT02516709
What this trial is testing

Linear Source Registry for Prostate Cancer

Who this might be right for
Prostate Cancer
CivaTech Oncology 60
Testing effectiveness (Phase 2)UnknownNCT00024414
What this trial is testing

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Theradex
Testing effectiveness (Phase 2)Ended earlyNCT00003516
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
Burzynski Research Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT05557604
What this trial is testing

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

Who this might be right for
Prostate Cancer
Regina Elena Cancer Institute 146
Testing effectiveness (Phase 2)Looking for participantsNCT06391034
What this trial is testing

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Robert Bok, MD, PhD 161
Not applicableUnknownNCT05941104
What this trial is testing

The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsFrailtyBlood Biological Indicators+2 more
Anhui Provincial Hospital 100
Not applicableStudy completedNCT00210249
What this trial is testing

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment

Who this might be right for
LymphomaDigestive System DiseasesOvarian Diseases+3 more
Institut Bergonié 364
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Not applicableLooking for participantsNCT05295407
What this trial is testing

Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Who this might be right for
Prostate Cancer
Endeavor Health 1,000
Next Page